Niffer, France

Alexander Baxter Smith

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Basel, CH (2016)
  • Niffer, FR (2014 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
7 patents (USPTO):

Title: Alexander Baxter Smith: A Trailblazer in Pharmaceutical Innovation

Introduction: Alexander Baxter Smith, a prolific inventor hailing from Niffer, France, has made significant contributions to the field of pharmaceutical innovation. With an impressive portfolio of 7 patents to his name, Smith's work has had a profound impact on the treatment of various diseases and disorders.

Latest Patents: Among his latest patents is the groundbreaking use of inhibitors of the activity or function of PI3K for the treatment of immunopathology in subjects suffering from diseases such as malaria, leishmaniasis, trypanosomiasis, toxoplasmosis, and neurocysticercosis. Additionally, Smith has formulated dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives that show promise in treating disorders mediated by the activity of PI3K enzymes.

Career Highlights: Smith is a key innovator at Novartis AG, a leading pharmaceutical company at the forefront of medical advancements. His relentless dedication to pushing the boundaries of science and medicine has positioned him as a trusted figure in the industry.

Collaborations: Throughout his career, Smith has collaborated closely with esteemed colleagues such as Nicolas Soldermann and Romain Wolf. Together, they have spearheaded research projects that have paved the way for groundbreaking pharmaceutical solutions.

Conclusion: Alexander Baxter Smith's exceptional talent, coupled with his unwavering commitment to innovation, continues to shape the landscape of pharmaceutical research and development. His patents stand as a testament to his ingenuity and serve as a source of inspiration for aspiring inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…